| [1] | Xiangxiang LI, Zhen WANG, Xing YANG, Suling LI. Research advances in the mechanism of action of traditional Chinese medicine in inhibiting angiogenesis in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2024, 40(7): 1477-1485. doi: 10.12449/JCH240729 |
| [2] | He Tao, Jiang Yu, Li Qiu, Fu WenGuang. Research advances in microvascular invasion in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2020, 36(5): 1185-1189. doi: 10.3969/j.issn.1001-5256.2020.05.053 |
| [3] | He XuChang, An WenHui, Zhao HaiQuan, Shen Hui, Yang Jing, Mo XiaoHua. Microvascular invasion in hepatocellular carcinoma:Definition and criteria for pathological grading[J]. Journal of Clinical Hepatology, 2020, 36(5): 1181-1184. doi: 10.3969/j.issn.1001-5256.2020.05.052 |
| [4] | Zhang YuPeng, Wang Fan, Chen PengFei, Liu Shi, Liu Lan, Chang Ying, Zhao Qiu. Expression and significance of the ABAT gene in hepatocellular carcinoma:An analysis based on data mining[J]. Journal of Clinical Hepatology, 2019, 35(3): 553-558. doi: 10.3969/j.issn.1001-5256.2019.03.020 |
| [5] | Zhang Yan, Xiang XiaoXing, Wang CuiMei. Expression and significance of the LONP1 gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(11): 2513-2516. doi: 10.3969/j.issn.1001-5256.2019.11.024 |
| [6] | Bai Xue, Ma ZuoHong, Hao ZhiQiang, Fu XiBo, Jiao Ao, Shang Hai, Hua XiangDong. Research advances in the risk factors for microvascular invasion in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2019, 35(11): 2578-2581. doi: 10.3969/j.issn.1001-5256.2019.11.042 |
| [7] | Ceng ChaiMing, Yan MaoLin, Shi YiHai, Guo TaiLin, Mei AiNong, Chen JianKang, Xu GuiPing, He XiaoHong. Changes in the expression of 17-β-hydroxysteroid dehydrogenase 13 and mitofusin 2 in liver cancer tissue and a bioinformatics analysis[J]. Journal of Clinical Hepatology, 2019, 35(12): 2736-2740. doi: 10.3969/j.issn.1001-5256.2019.12.019 |
| [8] | Wu YanBin, Wang XueWen, Niu HongKai, Cheng Yu. Research advances in the role of protective autophagy in regulating vasculogenic mimicry formation in malignancies such as cholangiocarcinoma[J]. Journal of Clinical Hepatology, 2019, 35(8): 1882-1884. doi: 10.3969/j.issn.1001-5256.2019.08.053 |
| [9] | Zang ChaoRan, Zhang YongHong. Role of immunosuppressive cells in the development and progression of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(7): 1560-1564. doi: 10.3969/j.issn.1001-5256.2018.07.042 |
| [10] | Yang GuiMin, Zhao YunSheng, Wang ChunHua, Jin Liang. Research advances in tumor markers for the diagnosis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2018, 34(1): 199-203. doi: 10.3969/j.issn.1001-5256.2018.01.044 |
| [11] | Wang Li, Shi Wei, Xue Jun, Pan CuiRan, Yao Min, Yao DengFu. Regulatory effect of abnormal expression of hypoxia- inducible factor- 1α on angiogenesis in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2017, 33(2): 369-374. doi: 10.3969/j.issn.1001-5256.2017.02.037 |
| [12] | Wang ShiMei, Wu Xia, Kang Peng, Meng QingYang. Diagnostic value of H19 gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(11): 2203-2205. doi: 10.3969/j.issn.1001-5256.2016.11.046 |
| [13] | Yang XiaoXiao, Ma Hong. Research advances in tumor markers of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2016, 32(4): 811-815. doi: 10.3969/j.issn.1001-5256.2016.04.047 |
| [14] | Ji Ru, Dou KeFeng, Xu Hui. Prevention and management of recurrence and metastasis of hepatocellular carcinoma after liver transplantation[J]. Journal of Clinical Hepatology, 2014, 30(1): 7-10. doi: 10.3969/j.issn.1001-5256.2014.01.003 |
| [15] | Ma DeNing, Zhu XiaoDong, Tang ZhaoYou. Role of cancer- associated fibroblasts in growth and metastasis of hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2014, 30(9): 865-868. doi: 10.3969/j.issn.1001-5256.2014.09.007 |
| [16] | Xing Jing, Han Tao, Zhu ZhengYan, Liu Ying, Liu Hua, Guo Zhen, Ma XiaoYan, Pei YanZhen. Serum thymosin β4 level in patients with hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(4): 387-390. |
| [17] | Li HaiPing, Tao JianShu, Gao Bo, Yu ZongTao, Li WenCui, Zhang JiCai. The expression and clinical significance of resistance gene in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(9): 972-975. |
| [18] | Zhang HuaMin, Zhao ZhengBin, Xiong YaXing, Chen Hong. Research progress of angiopoietins in hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2011, 27(4): 433-436. |
| [19] | Zhang HuiJing, Li ShengMian. Promoter methylation in APC, RASSF1A, WIF-1 gene in digestive system tumors[J]. Journal of Clinical Hepatology, 2011, 27(4): 429-432. |
DownLoad: